Show source-provided references
2. Natural products as sources of new drugs over the 30 years from 1981 to 2010
10.1021/np200906s ↗3. Thomford, N.E., Senthebane, D.A., Rowe, A., Munro, D., Seele, P., Maroyi, A., and Dzobo, K. (2018). Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int. J. Mol. Sci., 19.
10.3390/ijms19061578 ↗5. The re-emergence of natural products for drug discovery in the genomics era
10.1038/nrd4510 ↗6. Waltenberger, B., Mocan, A., Šmejkal, K., Heiss, E.H., and Atanasov, A.G. (2016). Natural products to counteract the epidemic of cardiovascular and metabolic disorders. Molecules, 21.
10.3390/molecules21060807 ↗7. The raison d’ĕtre of secondary plant substances; These odd chemicals arose as a means of protecting plants from insects and now guide insects to food
10.1126/science.129.3361.1466 ↗13. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
10.1016/S0169-409X(00)00129-0 ↗16. Natural product-informed exploration of chemical space to enable bioactive molecular discovery
10.1039/D0MD00376J ↗17. ChemGPS-NP: Tuned for navigation in biologically relevant chemical space
10.1021/np070002y ↗18. Grazina, L., Rodrigues, P.J., Igrejas, G., Nunes, M.A., Mafra, I., Arlorio, M., Oliveira, M.B.P.P., and Amaral, J.S. (2020). Machine learning approaches applied to GC-FID fatty acid profiles to discriminate wild from farmed salmon. Foods, 9.
10.3390/foods9111622 ↗23. Moon, S., Zhung, W., Yang, S., Lim, J., and Kim, W.Y. (2022). PIGNet: A physics-informed deep learning model toward generalized drug-target interaction predictions. Chem. Sci., in press.
10.1039/D1SC06946B ↗25. Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design
10.1021/acs.jcim.0c00411 ↗29. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules
33. 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
10.1128/AAC.37.7.1473 ↗36. NCBI (2018). Resource coordinators database resources of the national center for biotechnology information. Nucleic Acids Res., 46, D8–D13.
40. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
10.1073/pnas.0506580102 ↗47. ADMETlab: A platform for systematic ADMET evaluation based on a comprehensively collected ADMET database
10.1186/s13321-018-0283-x ↗52. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
10.1038/srep42717 ↗57. Patel, L., Shukla, T., Huang, X., Ussery, D.W., and Wang, S. (2020). Machine learning methods in drug discovery. Molecules, 25.
10.3390/molecules25225277 ↗58. Mirza, B., Wang, W., Wang, J., Choi, H., Chung, N.C., and Ping, P. (2019). Machine learning and integrative analysis of biomedical big data. Genes, 10.
10.3390/genes10020087 ↗60. Shin, B., Park, S., Kang, K., and Ho, J.C. (2019). Self-attention based molecule representation for predicting drug-target interaction. arXiv.
61. Making sense of large-scale kinase inhibitor bioactivity data sets: A comparative and integrative analysis
10.1021/ci400709d ↗65. A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters
10.1021/acs.jcim.0c01304 ↗66. A deep learning genome-mining strategy for biosynthetic gene cluster prediction
10.1093/nar/gkz654 ↗68. Distributed representations of words and phrases and their compositionality
71. Cholinesterase inhibitors as Alzheimer’s therapeutics (review)
73. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
10.1073/pnas.1320001111 ↗74. A computational method for unveiling the target promiscuity of pharmacologically active compounds
10.1002/anie.201706376 ↗76. PPARγ signaling and metabolism: The good, the bad and the future
10.1038/nm.3159 ↗78. From machine learning to natural product derivatives that selectively activate transcription factor PPARγ
10.1002/cmdc.200900469 ↗79. Zeidan, M., Rayan, M., Zeidan, N., Falah, M., and Rayan, A. (2017). Indexing natural products for their potential anti-diabetic activity: Filtering and mapping discriminative physicochemical properties. Molecules, 22.
10.3390/molecules22091563 ↗83. Nature is the best source of anti-inflammatory drugs: Indexing natural products for their anti-inflammatory bioactivity
10.1007/s00011-017-1096-5 ↗84. Novel potential agents for ulcerative colitis by molecular topology: Suppression of IL-6 production in Caco-2 and RAW 264.7 cell lines
10.1007/s11030-013-9458-6 ↗85. Prediction of anti-inflammatory plants and discovery of their biomarkers by machine learning algorithms and metabolomic studies
10.1055/s-0034-1396206 ↗86. Linardatos, P., Papastefanopoulos, V., and Kotsiantis, S. (2020). Explainable AI: A review of machine learning interpretability methods. Entropy, 23.
10.3390/e23010018 ↗89. Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents
10.1016/j.ejmech.2017.11.100 ↗90. Park, S., Ko, Y.H., Lee, B., Shin, B., and Beck, B.R. (2020, January 15). Abstract 35: Molecular optimization of phase III trial failed anticancer drugs using target affinity and toxicity-centered multiple properties reinforcement learning. Proceedings of the Poster Presentations—Proffered Abstracts, Ljubljana, Slovenia.
10.1158/1557-3265.ADVPRECMED20-35 ↗93. Shin, B., Park, S., Bak, J., and Ho, J.C. (2021, January 8). Controlled molecule generator for optimizing multiple chemical properties. Proceedings of the Conference on Health, Inference, and Learning, Virtual Event.
10.1145/3450439.3451879 ↗